Timothy Beukelman

11.3k total citations · 2 hit papers
116 papers, 5.3k citations indexed

About

Timothy Beukelman is a scholar working on Hematology, Speech and Hearing and Rheumatology. According to data from OpenAlex, Timothy Beukelman has authored 116 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 76 papers in Hematology, 44 papers in Speech and Hearing and 42 papers in Rheumatology. Recurrent topics in Timothy Beukelman's work include Autoimmune and Inflammatory Disorders Research (75 papers), Adolescent and Pediatric Healthcare (44 papers) and Rheumatoid Arthritis Research and Therapies (22 papers). Timothy Beukelman is often cited by papers focused on Autoimmune and Inflammatory Disorders Research (75 papers), Adolescent and Pediatric Healthcare (44 papers) and Rheumatoid Arthritis Research and Therapies (22 papers). Timothy Beukelman collaborates with scholars based in United States, Canada and Germany. Timothy Beukelman's co-authors include Randy Q. Cron, Kenneth G. Saag, Jeffrey R. Curtis, Fenglong Xie, Lang Chen, Yukiko Kimura, James D. Lewis, Elizabeth Delzell, Esi Morgan DeWitt and Norman T. Ilowite and has published in prestigious journals such as JAMA, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Timothy Beukelman

112 papers receiving 5.2k citations

Hit Papers

2011 American College of ... 2011 2026 2016 2021 2011 2019 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: Initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features
    2011 549 citations Timothy Beukelman, Nivedita M. Patkar et al. Arthritis Care & Research profile →
  2. Benefit of Anakinra in Treating Pediatric Secondary Hemophagocytic Lymphohistiocytosis
    2019 187 citations Melissa L. Mannion, Matthew L. Stoll et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Timothy Beukelman 3.3k 2.0k 1.4k 1.1k 959 116 5.3k
Gerd Horneff 3.2k 1.0× 1.3k 0.7× 1.4k 1.1× 1.6k 1.5× 847 0.9× 324 5.5k
Norman T. Ilowite 4.3k 1.3× 1.6k 0.8× 2.1k 1.5× 1.4k 1.2× 1.4k 1.4× 112 6.0k
Athimalaipet V Ramanan 2.4k 0.7× 1.3k 0.7× 486 0.4× 1.2k 1.1× 1.0k 1.1× 169 4.6k
Tomoyuki Imagawa 1.5k 0.4× 718 0.4× 501 0.4× 853 0.8× 896 0.9× 150 3.3k
Alexei A. Grom 5.0k 1.5× 799 0.4× 1.4k 1.1× 3.6k 3.3× 1.4k 1.5× 122 7.4k
Nivedita M. Patkar 1.0k 0.3× 1.1k 0.6× 363 0.3× 484 0.4× 550 0.6× 29 2.9k
Fenglong Xie 1.0k 0.3× 2.1k 1.1× 202 0.1× 882 0.8× 483 0.5× 140 4.3k
Thomas J A Lehman 790 0.2× 1.6k 0.8× 245 0.2× 1.1k 1.0× 1.3k 1.3× 106 4.2k
Matthew L. Stoll 1.2k 0.3× 938 0.5× 355 0.3× 422 0.4× 290 0.3× 86 2.4k
Edward M. Behrens 1.9k 0.6× 298 0.2× 477 0.3× 2.0k 1.8× 1.7k 1.8× 101 5.1k

Countries citing papers authored by Timothy Beukelman

Since Specialization
Citations

This map shows the geographic impact of Timothy Beukelman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timothy Beukelman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timothy Beukelman more than expected).

Fields of papers citing papers by Timothy Beukelman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timothy Beukelman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timothy Beukelman. The network helps show where Timothy Beukelman may publish in the future.

Co-authorship network of co-authors of Timothy Beukelman

This figure shows the co-authorship network connecting the top 25 collaborators of Timothy Beukelman. A scholar is included among the top collaborators of Timothy Beukelman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Timothy Beukelman. Timothy Beukelman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mannion, Melissa L., Stephen J. Balevic, Min‐Lee Chang, et al.. (2024). Comparative Effectiveness of a Second Tumor Necrosis Factor Inhibitor Versus a Non–Tumor Necrosis Factor Biologic in the Treatment of Patients With Polyarticular‐Course Juvenile Idiopathic Arthritis. Arthritis Care & Research. 76(8). 1090–1098. 2 indexed citations
2.
Sattui, Sebastian E., Frank Buttgereit, Stefano Fiore, et al.. (2024). POS1460-HPR PREVALENCE AND MANAGEMENT OF PATIENTS WITH COMORBIDITIES AND FRAILTY IN NEW ONSET POLYMYALGIA RHEUMATICA. Annals of the Rheumatic Diseases. 83. 1187–1188. 1 indexed citations
3.
Beukelman, Timothy, Amy S. Mudano, Shilpa Venkatachalam, et al.. (2024). Generating Real‐World Evidence From the Excellence Network in Rheumatology. Pharmacoepidemiology and Drug Safety. 33(12). e70067–e70067. 1 indexed citations
4.
Jackson, Lesley E., et al.. (2023). Prediction of Survival by IL-6 in a Randomized Placebo-Controlled Trial of Anakinra in COVID-19 Cytokine Storm. Viruses. 15(10). 2036–2036. 3 indexed citations
5.
Correll, C., Scott Stryker, David H. Collier, et al.. (2023). Occurrence of adverse events and change in disease activity after initiation of etanercept in paediatric patients with juvenile psoriatic arthritis in the CARRA Registry. RMD Open. 9(2). e002943–e002943. 1 indexed citations
6.
Beukelman, Timothy, Millie D. Long, Rennie L. Rhee, et al.. (2023). Assessment of Real-World Patient-Reported Outcomes in Patients Initiating Biologic Agents for the Treatment of Autoimmune Diseases: An Observational Study in Four Patient-Powered Research Networks. Patient Related Outcome Measures. Volume 14. 171–180. 1 indexed citations
7.
Beukelman, Timothy, Lang Chen, Narender Annapureddy, et al.. (2023). Using pooled electronic health records data to conduct pharmacoepidemiology safety studies: Challenges and lessons learned. Pharmacoepidemiology and Drug Safety. 32(9). 969–977. 3 indexed citations
8.
Santoro, Jonathan D., Timothy Beukelman, Cheryl Hemingway, et al.. (2023). Attack phenotypes and disease course in pediatric MOGAD. Annals of Clinical and Translational Neurology. 10(5). 672–685. 11 indexed citations
9.
10.
Mannion, Melissa L., Fenglong Xie, Daniel B. Horton, et al.. (2020). Biologic Switching Among Nonsystemic Juvenile Idiopathic Arthritis Patients: A Cohort Study in the Childhood Arthritis and Rheumatology Research Alliance Registry. The Journal of Rheumatology. 48(8). 1322–1329. 14 indexed citations
11.
Horton, Daniel B., Timothy Beukelman, Alexis Boneparth, et al.. (2019). Making Decisions About Stopping Medicines for Well‐Controlled Juvenile Idiopathic Arthritis: A Mixed‐Methods Study of Patients and Caregivers. Arthritis Care & Research. 73(3). 374–385. 20 indexed citations
12.
13.
Gmuca, Sabrina, Rui Xiao, Timothy G. Brandon, et al.. (2017). Multicenter inception cohort of enthesitis-related arthritis: variation in disease characteristics and treatment approaches. Arthritis Research & Therapy. 19(1). 84–84. 42 indexed citations
14.
Curtis, Jeffrey R., Fenglong Xie, David A. Mackey, et al.. (2016). Patient’s experience with subcutaneous and oral methotrexate for the treatment of rheumatoid arthritis. BMC Musculoskeletal Disorders. 17(1). 405–405. 21 indexed citations
15.
Tambralli, Ajay, Timothy Beukelman, Peter Weiser, et al.. (2013). High Doses of Infliximab in the Management of Juvenile Idiopathic Arthritis. The Journal of Rheumatology. 40(10). 1749–1755. 38 indexed citations
16.
Baddley, John W., Kevin Winthrop, Lang Chen, et al.. (2013). Non-viral opportunistic infections in new users of tumour necrosis factor inhibitor therapy: results of the SAfety Assessment of Biologic ThERapy (SABER) Study. Annals of the Rheumatic Diseases. 73(11). 1942–1948. 94 indexed citations
17.
Mannion, Melissa L., et al.. (2012). Sarcoidosis in a young child with Alagille syndrome: a case report. Pediatric Rheumatology. 10(1). 32–32. 4 indexed citations
18.
Beukelman, Timothy, Nivedita M. Patkar, Kenneth G. Saag, et al.. (2011). 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: Initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features. Arthritis Care & Research. 63(4). 465–482. 549 indexed citations breakdown →
19.
20.
Atkinson, T. Prescott, Claas Hinze, Shehzad A. Saeed, et al.. (2009). Rituximab Therapy for Severe Refractory Chronic Henoch-Schönlein Purpura. The Journal of Pediatrics. 155(1). 136–139. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gerd Horneff Breakdown of academic impact, for papers by Norman T. Ilowite Breakdown of academic impact, for papers by Athimalaipet V Ramanan Breakdown of academic impact, for papers by Tomoyuki Imagawa Breakdown of academic impact, for papers by Alexei A. Grom Breakdown of academic impact, for papers by Nivedita M. Patkar Breakdown of academic impact, for papers by Fenglong Xie Breakdown of academic impact, for papers by Thomas J A Lehman Breakdown of academic impact, for papers by Matthew L. Stoll Breakdown of academic impact, for papers by Edward M. Behrens
Rankless by CCL
2026